...intermediate results were outstanding on the double blind, world wide, trial. I really don't see how the FDA can not approve Genasense this time around.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.